Free Trial
NASDAQ:REVBW

Revelation Biosciences (REVBW) Stock Price, News & Analysis

$0.01 0.00 (0.00%)
As of 05/30/2025

About Revelation Biosciences Stock (NASDAQ:REVBW)

Key Stats

Today's Range
$0.0119
$0.0119
50-Day Range
$0.0097
$0.0157
52-Week Range
$0.00
$0.04
Volume
N/A
Average Volume
85,500 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.

Receive REVBW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter.

REVBW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

REVBW Stock Analysis - Frequently Asked Questions

Revelation Biosciences' stock was trading at $0.0070 at the beginning of the year. Since then, REVBW shares have increased by 70.0% and is now trading at $0.0119.
View the best growth stocks for 2025 here
.

Revelation Biosciences' top institutional investors include Quaker Wealth Management LLC.

Shares of REVBW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:REVBW
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:REVBW) was last updated on 6/2/2025 by MarketBeat.com Staff
From Our Partners